Bharat Parenterals Ltd vs Laurus Labs Limited
A side-by-side comparison of Bharat Parenterals Ltd (541096) and Laurus Labs Limited (LAURUSLABS) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Laurus Labs Limited leads 541096 vs LAURUSLABS on 9 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability04
- Growth10
- Size & financial health13
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
LAURUSLABS takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
541096 takes 1/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
LAURUSLABS takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- − ["Stock is trading at 3.28 times its book value", "Company has low interest coverage ratio.", "Company has a low return on equity of -0.79% over last 3 years.", "Company might be capitalizing the interest cost", "Earnings include an other income of Rs.9.60 Cr.", "Company has high debtors of 159 days.", "Promoter holding has decreased over last 3 years: -6.64%", "Working capital days have increased from 100 days to 143 days"]
- + []
- − ["Stock is trading at 24.39 times its book value", "The company has delivered a poor sales growth of 7.2% over past five years.", "The company has delivered a poor profit growth of -2.0% over past five years."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.